Parnassus Investments
MRNA icon

Parnassus Investments’s Moderna MRNA Stock Holding History

Parnassus Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-644,208
Closed -$66.5M – 140
2023
Q3 		$66.5M Hold
644,208
– – 0.16% 94
2023
Q2 		$78.3M Hold
644,208
– – 0.18% 89
2023
Q1 		$98.9M Hold
644,208
– – 0.25% 79
2022
Q4 		$116M Sell
644,208
-53,393
-8% -$8.73M 0.29% 73
2022
Q3 		$82.5M Buy
697,601
+97,761
+16% +$14.8M 0.21% 79
2022
Q2 		$85.7M Hold
599,840
– – 0.2% 90
2022
Q1 		$103M Buy
+599,840
New +$101M 0.21% 94

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Parnassus Investments's MRNA Position: Q4 2023 in Review

Parnassus Investments sold out of Moderna (MRNA) in Q4 2023, closing a stake of 644,208 shares — an estimated $66.5M sold.

Parnassus Investments first reported a position in MRNA in Q1 2022 and held it in 7 quarters. The position peaked at $116M in Q4 2022. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Parnassus Investments reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Parnassus Investments sold 644,208 Moderna shares in Q4 2023, an estimated $66.5M.
  • Parnassus Investments first reported a position in Moderna in Q1 2022 and held it in 7 quarters.
  • Parnassus Investments's Moderna position peaked at $116M in Q4 2022.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Parnassus Investments's 13F filing for Q4 2023, filed 12 Feb 2024.